How Abbott’s Newest Indication Is Reshaping Heart Failure Management

Abbott Laboratories’ CardioMems sensor is changing the way pulmonary arterial pressures are monitored and managed in heart failure patients. And now, with a recent nod from FDA, the CardioMems HF System has an indication that will allow it to reach an additional 1.2 million people living with heart failure.